share_log

CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

SEC ·  May 17, 2022 04:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more